Pruthi, Raj S.

Trends in stage‐specific incidence rates for urothelial carcinoma of the bladder in the United States: 1988 to 2006

Nielsen, M. E., Smith, A. B., Meyer, A., Kuo, T., Tyree, S., Kim, W. Y., Milowsky, M. I., Pruthi, R. S., & Millikan, R. C. (2014) · Cancer

Bladder and Urothelial Cancer TreatmentsUrinary and Genital Oncology Studies

Cited by 149

Data from Heterogeneity in NECTIN4 Expression Across Molecular Subtypes of Urothelial Cancer Mediates Sensitivity to Enfortumab Vedotin

Chu, C. E., Sjöström, M., Egusa, E. A., Gibb, E. A., Badura, M. L., Zhu, J., Koshkin, V. S., Stohr, B. A., Meng, M. V., Pruthi, R. S., et al. (2023)

Bladder and Urothelial Cancer TreatmentsUrinary Bladder and Prostate Research

Cited by 0

Data from Heterogeneity in NECTIN4 Expression Across Molecular Subtypes of Urothelial Cancer Mediates Sensitivity to Enfortumab Vedotin

Chu, C. E., Sjöström, M., Egusa, E. A., Gibb, E. A., Badura, M. L., Zhu, J., Koshkin, V. S., Stohr, B. A., Meng, M. V., Pruthi, R. S., et al. (2023)

Bladder and Urothelial Cancer TreatmentsUrinary Bladder and Prostate Research

Cited by 0